Journal of Clinical Microbiology · 2011 · 19 citations · 12 references
Veterinary MedicineInfectious DiseasesDiagnostic MicrobiologyMedical MicrobiologyTuberculosis ControlAntibiotic ResistanceAntimicrobial Susceptibility TestingTuberculosis DiagnosisTuberculosis Diagnostic TestingAntibacterial Susceptibility TestingDrug Resistance TestingMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility Testing
The purpose of this study was to establish a standardized protocol for second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis using the Bactec MGIT 960 system in Canadian laboratories. Four Canadian public health laboratories compared the susceptibility testing results of 9 second-line antimicrobials between the Bactec 460 and Bactec MGIT 960 systems. Based on the data generated, we have established that the Bactec MGIT 960 system provides results comparable to those obtained with the previous Bactec 460 method. The critical concentrations established for the testing of the antimicrobials used are as follows: amikacin, 1 μg/ml; capreomycin, 2.5 μg/ml; ethionamide, 5 μg/ml; kanamycin, 2.5 μg/ml; linezolid, 1 μg/ml; moxifloxacin, 0.25 μg/ml; ofloxacin, 2 μg/ml; p-aminosalicylic acid, 4 μg/ml; rifabutin, 0.5 μg/ml.
12
Policy Guidance on Drug-Susceptibility Testing (DST) of Second-Line Antituberculosis Drugs
L Barrera, E Cooreman, de Dieu Iragena J et al. · 2008 · 227 citations
Sabine Rüsch–Gerdes, Gaby E. Pfyffer, Manuel Casal et al. · Journal of Clinical Microbiology · 2006 · 212 citations · Full text
Veterinary Medicine, Pharmacology, Antimicrobial Pharmacology +14
Pascale Bémer, Frantiska Palicova, Sabine Rüsch–Gerdes et al. · Journal of Clinical Microbiology · 2002 · 174 citations
Gaby E. Pfyffer, Donald A. Bonato, Adeleh Ebrahimzadeh et al. · Journal of Clinical Microbiology · 1999 · 133 citations · Full text
Veterinary Medicine, Pharmacology, Antimicrobial Pharmacotherapy +13